Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice.
Iwama T, Uchida T, Sawada Y, Tsuchiya N, Sugai S, Fujinami N, Shimomura M, Yoshikawa T, Zhang R, Uemura Y, Nakatsura T. Iwama T, et al. Among authors: fujinami n. Biochem Biophys Res Commun. 2016 Jan 1;469(1):138-143. doi: 10.1016/j.bbrc.2015.11.084. Epub 2015 Nov 23. Biochem Biophys Res Commun. 2016. PMID: 26616051 Free article.
Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.
Tsuchiya N, Hosono A, Yoshikawa T, Shoda K, Nosaka K, Shimomura M, Hara J, Nitani C, Manabe A, Yoshihara H, Hosoya Y, Kaneda H, Kinoshita Y, Kohashi K, Yoshimura K, Fujinami N, Saito K, Mizuno S, Nakatsura T. Tsuchiya N, et al. Among authors: fujinami n. Oncoimmunology. 2017 Sep 27;7(1):e1377872. doi: 10.1080/2162402X.2017.1377872. eCollection 2017. Oncoimmunology. 2017. PMID: 29296538 Free PMC article.
Peptide vaccine as an adjuvant therapy for glypican-3-positive hepatocellular carcinoma induces peptide-specific CTLs and improves long prognosis.
Taniguchi M, Mizuno S, Yoshikawa T, Fujinami N, Sugimoto M, Kobayashi S, Takahashi S, Konishi M, Gotohda N, Nakatsura T. Taniguchi M, et al. Among authors: fujinami n. Cancer Sci. 2020 Aug;111(8):2747-2759. doi: 10.1111/cas.14497. Epub 2020 Jun 18. Cancer Sci. 2020. PMID: 32449239 Free PMC article. Clinical Trial.
Plasma and tumoral glypican-3 levels are correlated in patients with hepatitis C virus-related hepatocellular carcinoma.
Shimizu Y, Mizuno S, Fujinami N, Suzuki T, Saito K, Konishi M, Takahashi S, Gotohda N, Tada T, Toyoda H, Kumada T, Miura M, Suto K, Yamaji T, Matsuda T, Endo I, Nakatsura T. Shimizu Y, et al. Among authors: fujinami n. Cancer Sci. 2020 Feb;111(2):334-342. doi: 10.1111/cas.14251. Epub 2019 Dec 28. Cancer Sci. 2020. PMID: 31774932 Free PMC article.
33 results